vs
CITY HOLDING CO（CHCO）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
CITY HOLDING CO的季度营收约是RIGEL PHARMACEUTICALS INC的1.1倍（$80.2M vs $69.8M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 39.4%，领先344.7%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs 11.8%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 5.3%）
Jam City是一家总部位于美国加州卡尔弗城的电子游戏开发及发行商，由克里斯·德沃尔夫等四人于2010年联合创立。目前公司在美、加、南美及欧洲共设有9个工作室，2021年时员工规模达825人，最大股东为网石。截至2021年，旗下游戏月活用户达3100万，累计总下载量超13亿次。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
CHCO vs RIGL — 直观对比
营收规模更大
CHCO
是对方的1.1倍
$69.8M
营收增速更快
RIGL
高出9.4%
11.8%
净利率更高
RIGL
高出344.7%
39.4%
两年增速更快
RIGL
近两年复合增速
5.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $80.2M | $69.8M |
| 净利润 | $31.6M | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | 49.3% | 33.2% |
| 净利率 | 39.4% | 384.0% |
| 营收同比 | 11.8% | 21.2% |
| 净利润同比 | 10.2% | 1769.2% |
| 每股收益（稀释后） | $2.17 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CHCORIGL
| Q4 25 | $80.2M | $69.8M | ||
| Q3 25 | $81.3M | $69.5M | ||
| Q2 25 | $78.2M | $101.7M | ||
| Q1 25 | $74.6M | $53.3M | ||
| Q4 24 | $71.7M | $57.6M | ||
| Q3 24 | $76.0M | $55.3M | ||
| Q2 24 | $73.5M | $36.8M | ||
| Q1 24 | $72.4M | $29.5M |
净利润CHCORIGL
| Q4 25 | $31.6M | $268.1M | ||
| Q3 25 | $35.2M | $27.9M | ||
| Q2 25 | $33.4M | $59.6M | ||
| Q1 25 | $30.3M | $11.4M | ||
| Q4 24 | $28.7M | $14.3M | ||
| Q3 24 | $29.8M | $12.4M | ||
| Q2 24 | $29.1M | $-1.0M | ||
| Q1 24 | $29.5M | $-8.2M |
毛利率CHCORIGL
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% | ||
| Q1 24 | — | 93.1% |
营业利润率CHCORIGL
| Q4 25 | 49.3% | 33.2% | ||
| Q3 25 | 54.0% | 40.9% | ||
| Q2 25 | 52.7% | 60.1% | ||
| Q1 25 | 49.5% | 23.9% | ||
| Q4 24 | 48.1% | 28.9% | ||
| Q3 24 | 48.9% | 25.4% | ||
| Q2 24 | 49.3% | 1.2% | ||
| Q1 24 | 50.6% | -23.6% |
净利率CHCORIGL
| Q4 25 | 39.4% | 384.0% | ||
| Q3 25 | 43.3% | 40.2% | ||
| Q2 25 | 42.7% | 58.6% | ||
| Q1 25 | 40.7% | 21.5% | ||
| Q4 24 | 40.0% | 24.9% | ||
| Q3 24 | 39.2% | 22.5% | ||
| Q2 24 | 39.6% | -2.8% | ||
| Q1 24 | 40.8% | -27.9% |
每股收益（稀释后）CHCORIGL
| Q4 25 | $2.17 | $14.11 | ||
| Q3 25 | $2.41 | $1.46 | ||
| Q2 25 | $2.29 | $3.28 | ||
| Q1 25 | $2.06 | $0.63 | ||
| Q4 24 | $1.94 | $0.82 | ||
| Q3 24 | $2.02 | $0.70 | ||
| Q2 24 | $1.96 | $-0.06 | ||
| Q1 24 | $1.97 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $191.9M | $155.0M |
| 总债务越低越好 | $150.0M | $52.5M |
| 股东权益账面价值 | $809.7M | $391.5M |
| 总资产 | $6.7B | $513.6M |
| 负债/权益比越低杠杆越低 | 0.19× | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资CHCORIGL
| Q4 25 | $191.9M | $155.0M | ||
| Q3 25 | $225.6M | $137.1M | ||
| Q2 25 | $172.1M | $108.4M | ||
| Q1 25 | $384.7M | $77.1M | ||
| Q4 24 | $225.4M | $77.3M | ||
| Q3 24 | $293.9M | $61.1M | ||
| Q2 24 | $218.0M | $49.1M | ||
| Q1 24 | $318.7M | $49.5M |
总债务CHCORIGL
| Q4 25 | $150.0M | $52.5M | ||
| Q3 25 | $150.0M | $60.0M | ||
| Q2 25 | $150.0M | $60.0M | ||
| Q1 25 | $150.0M | $60.0M | ||
| Q4 24 | $150.0M | $60.0M | ||
| Q3 24 | $150.0M | $60.0M | ||
| Q2 24 | $150.0M | $60.0M | ||
| Q1 24 | $150.0M | $60.0M |
股东权益CHCORIGL
| Q4 25 | $809.7M | $391.5M | ||
| Q3 25 | $798.9M | $117.6M | ||
| Q2 25 | $764.2M | $81.9M | ||
| Q1 25 | $756.3M | $18.6M | ||
| Q4 24 | $730.7M | $3.3M | ||
| Q3 24 | $741.3M | $-14.6M | ||
| Q2 24 | $686.7M | $-29.9M | ||
| Q1 24 | $682.2M | $-31.7M |
总资产CHCORIGL
| Q4 25 | $6.7B | $513.6M | ||
| Q3 25 | $6.7B | $242.5M | ||
| Q2 25 | $6.6B | $206.7M | ||
| Q1 25 | $6.6B | $176.0M | ||
| Q4 24 | $6.5B | $164.0M | ||
| Q3 24 | $6.4B | $139.4M | ||
| Q2 24 | $6.3B | $128.4M | ||
| Q1 24 | $6.3B | $126.5M |
负债/权益比CHCORIGL
| Q4 25 | 0.19× | 0.13× | ||
| Q3 25 | 0.19× | 0.51× | ||
| Q2 25 | 0.20× | 0.73× | ||
| Q1 25 | 0.20× | 3.23× | ||
| Q4 24 | 0.21× | 18.25× | ||
| Q3 24 | 0.20× | — | ||
| Q2 24 | 0.22× | — | ||
| Q1 24 | 0.22× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $131.4M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $128.4M | — |
| 自由现金流率自由现金流/营收 | 160.2% | — |
| 资本支出强度资本支出/营收 | 3.6% | — |
| 现金转化率经营现金流/净利润 | 4.16× | 0.08× |
| 过去12个月自由现金流最近4个季度 | $223.3M | — |
8季度趋势，按日历期对齐
经营现金流CHCORIGL
| Q4 25 | $131.4M | $22.0M | ||
| Q3 25 | $37.3M | $24.0M | ||
| Q2 25 | $28.2M | $30.5M | ||
| Q1 25 | $31.5M | $-893.0K | ||
| Q4 24 | $131.9M | $14.5M | ||
| Q3 24 | $37.6M | $21.7M | ||
| Q2 24 | $28.3M | $302.0K | ||
| Q1 24 | $32.2M | $-5.0M |
自由现金流CHCORIGL
| Q4 25 | $128.4M | — | ||
| Q3 25 | $35.8M | — | ||
| Q2 25 | $27.8M | — | ||
| Q1 25 | $31.3M | — | ||
| Q4 24 | $129.2M | — | ||
| Q3 24 | $37.0M | — | ||
| Q2 24 | $27.8M | — | ||
| Q1 24 | $31.6M | — |
自由现金流率CHCORIGL
| Q4 25 | 160.2% | — | ||
| Q3 25 | 44.0% | — | ||
| Q2 25 | 35.6% | — | ||
| Q1 25 | 41.9% | — | ||
| Q4 24 | 180.2% | — | ||
| Q3 24 | 48.7% | — | ||
| Q2 24 | 37.8% | — | ||
| Q1 24 | 43.6% | — |
资本支出强度CHCORIGL
| Q4 25 | 3.6% | — | ||
| Q3 25 | 1.9% | — | ||
| Q2 25 | 0.5% | — | ||
| Q1 25 | 0.3% | — | ||
| Q4 24 | 3.8% | — | ||
| Q3 24 | 0.9% | — | ||
| Q2 24 | 0.7% | — | ||
| Q1 24 | 0.8% | — |
现金转化率CHCORIGL
| Q4 25 | 4.16× | 0.08× | ||
| Q3 25 | 1.06× | 0.86× | ||
| Q2 25 | 0.85× | 0.51× | ||
| Q1 25 | 1.04× | -0.08× | ||
| Q4 24 | 4.60× | 1.01× | ||
| Q3 24 | 1.26× | 1.75× | ||
| Q2 24 | 0.97× | — | ||
| Q1 24 | 1.09× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
